Vir Biotechnology Inc (VIR)
Number of days of payables
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided for Vir Biotechnology Inc indicates that the number of days of payables is not available or not disclosed for the periods from March 31, 2020, to December 31, 2024. As a result, it is not possible to perform a detailed analysis of the trend or level of payables turnover efficiency based on this information. Companies usually disclose the number of days of payables to provide insights into how long it takes for the company to pay its outstanding liabilities to suppliers or vendors.
Without specific data on the number of days of payables, it is not possible to evaluate the company's ability to manage its trade credit effectively, optimize cash flow, or assess its relationships with suppliers. Investors and analysts typically use this ratio to understand the efficiency of a company's working capital management and its relationships with its supply chain partners.
In order to gain a complete understanding of Vir Biotechnology Inc's payables turnover efficiency, it would be essential to have access to the missing data points in the form of the number of days of payables for the relevant periods.
Peer comparison
Dec 31, 2024